R&D Partner Content mRNA Assay Development Summit 2023 Creating Better mRNA Drugs with Validated, Reliable & Reproducible Assays
R&D Partner Content 2nd Molecular Glue Drug Development Summit 2024 Accelerating the Next-Generation of Molecular Glues into the Clinic
R&D Partner Content 4th Annual CRISPR 2.0 2023 CRISPR represents the next frontier in the cell and gene therapy landscape.
R&D Partner Content CRISPR-Based Therapy Analytical Development Summit CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.
R&D Partner Content 3rd mRNA-Based Therapeutics Summit Europe 250+ mRNA Specialists | 40+ World-Class Speakers | 2 Streams of Content
R&D Partner Content 5th Inflammasome Therapeutics Summit returns to Boston! Advancing Inflammasome Therapeutics from Bench to In-Human Efficacy
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
